Literature DB >> 23129570

Drug-drug interaction between methotrexate and levetiracetam in a child treated for acute lymphoblastic leukemia.

Anne-Sophie Parentelli, Aurélie Phulpin-Weibel, Ludovic Mansuy, Audrey Contet, Philippe Trechot, Pascal Chastagner.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23129570     DOI: 10.1002/pbc.24371

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


× No keyword cloud information.
  6 in total

1.  Population-Based Study of Risk of AKI with Levetiracetam.

Authors:  Kevin Yau; Jorge G Burneo; Racquel Jandoc; Eric McArthur; Flory Tsobo Muanda; Chirag R Parikh; Ron Wald; Matthew A Weir; Amit X Garg
Journal:  Clin J Am Soc Nephrol       Date:  2018-12-11       Impact factor: 8.237

2.  Effect of Levetiracetam on Time to High-Dose Methotrexate Clearance in Patients With Hematologic Malignancies.

Authors:  Uvette Lou; Jamie Kwok; Thu Anne Nguyen; Allen Zhou; Samantha O Luk
Journal:  J Clin Pharmacol       Date:  2019-11-14       Impact factor: 3.126

3.  Lack of drug interaction between levetiracetam and high-dose methotrexate in patients with lymphoma.

Authors:  Catherine E DeFino; Jason N Barreto; Amanda G Pawlenty; Michael W Ruff; Ivan D Carabenciov; Kristin C Mara; Carrie A Thompson
Journal:  Pharmacotherapy       Date:  2021-03-16       Impact factor: 6.251

4.  Intravenous levetiracetam in critically ill children.

Authors:  Faruk Incecik; Ozden O Horoz; Ozlem M Herguner; Dincer Yıldızdas; Seyda Besen; Ilknur Tolunay; Sakir Altunbasak
Journal:  Ann Indian Acad Neurol       Date:  2016 Jan-Mar       Impact factor: 1.383

Review 5.  Preventing and Managing Toxicities of High-Dose Methotrexate.

Authors:  Scott C Howard; John McCormick; Ching-Hon Pui; Randall K Buddington; R Donald Harvey
Journal:  Oncologist       Date:  2016-08-05

Review 6.  Safety of Levetiracetam in Paediatrics: A Systematic Review.

Authors:  Oluwaseun Egunsola; Imti Choonara; Helen Mary Sammons
Journal:  PLoS One       Date:  2016-03-01       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.